Filing Details

Accession Number:
0001209191-23-000878
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-04 16:14:41
Reporting Period:
2022-12-30
Accepted Time:
2023-01-04 16:14:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1445283 Kineta Inc. KA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1730052 J. Raymond Bartoszek C/O Kineta, Inc.
219 Terry Ave. N., Suite 300
Seattle WA 98109
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-30 5,000 $6.23 9,956 No 4 P Direct
Common Stock Acquisiton 2022-12-30 1,001 $6.23 1,001 No 4 P Indirect By son
Common Stock Acquisiton 2022-12-30 1,000 $6.23 1,000 No 4 P Indirect By daughter
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect By son
No 4 P Indirect By daughter
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 61,585 Indirect By RLB Holdings, LLC
Common Stock 722,875 Indirect RLB Holdings Connecticut LLC
Footnotes
  1. The Reporting Person is a managing member of RLB Holdings, LLC ("RLB Holdings") and RLB Holdings Connecticut LLC ("RLB Connecticut") and shares voting and dispositive power over the shares held by RLB Holdings and RLB Connecticut. As such, the Reporting Person may be deemed to beneficially own such shares held by RLB Holdings and RLB Connecticut.